Transgene Biotek Ltd — Board Meeting, 30-07-2025: Board Meeting

Transgene Biotek Limited has announced a board meeting to consider key items. The agenda includes reviewing the financial results for the quarter, deliberating on the extension of the Annual General Meeting (AGM) for the 2024-25 financial year, and approving the appointment of both secretarial and internal auditors. This meeting is crucial for updating stakeholders on the company's financial performance and corporate governance. The trading window for the company's shares remains closed until 48 hours after the financial results are publicly released.